{rfName}
Ep

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Mascaro, R SiveraAuthor

Share

February 13, 2025
Publications
>
Article

Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

Publicated to:Neurologia. 38 (6): 379-386 - 2023-08-01 38(6), DOI: 10.1016/j.nrl.2021.01.006

Authors: Suero, GO; Abildúa, MJA; Munuera, CS; Axpe, IR; Gutiérrez, FJA; Gómez, ADA; de Rivera, FJR; Castro, BQ; Rodríguez, IP; Bermejo, AV; Santos, AD; Vicente, EB; Ceberio, II; Fernández, JP; Arpín, EC; Martí, CP; Muñoz, JE; Rivera, PM; Alvarez, FM; Alberola, LB; Bayarri, JG; Pons, CC; Santamaria, VV; Munain, ALD; Fernandez-Eulate, G; Abío, JG; Gallego, IS; Bartolomé, LR; Martín, OA; Martín, TS; Mingot, CG; Rovira, MB; Mascaró, RS; Delgado, EC; Iñiguez, AE; Sánchez, FV; Iglesias, MB; Codina, MTC; Fernández, EMM; Guerra, CL; Perna, BA; Hernández, AC; Moreno, CF; Larroy, MP; Pons, NC; Rivera, AA; Barrero, FJN; Rodríguez, RL; Gómez, MJS

Affiliations

Fdn Publ Galega Med Xen, Santiago De Compostela, Spain - Author
Hosp Alcazar San Juan, Complejo Mancha Ctr, Serv Neurol, Ciudad Real, Spain - Author
Hosp Arnau Vilanova, Serv Neurol, Lleida, Spain - Author
Hosp Clin Santiago de Compostela, Serv Neurol, Galicia, Spain - Author
Hosp Ernest Lluch, Serv Dermatol, Zaragoza, Spain - Author
Hosp Francesc de Borja, Serv Neurol, Gandia, Spain - Author
Hosp G Tomelloso, Serv Neurol, Ciudad Real, Spain - Author
Hosp Moises Broggi, Secc Neurol, Barcelona, Spain - Author
Hosp Nuestra Senora Candelaria, Serv Neurol, Tenerife, Spain - Author
Hosp Quiron A Coruna, Unidad Neurogenet, La Coruna, Spain - Author
Hosp Sabadell, Serv Neurol, Barcelona, Spain - Author
Hosp Ssnt Jaume de Calella, Serv Neurol, Barcelona, Spain - Author
Hosp St Joan Deu, Serv Neurol, Martorell, Spain - Author
Hosp Unit Mancha Ctr, Serv Neurol, Ciudad Real, Spain - Author
Hosp Univ 12 Octubre, Serv Neurol, Madrid, Spain - Author
Hosp Univ Albacete, Serv Neurol, Albacete, Spain - Author
Hosp Univ Alvaro Cunqueiro, Serv Neurol, Vigo, Spain - Author
Hosp Univ Bellvitge, Serv Neurol, Barcelona, Spain - Author
Hosp Univ Burgos, Serv Neurol, Burgos, Spain - Author
Hosp Univ Clin, Serv Neurol, Unidad Neurogenet, Barcelona, Spain - Author
Hosp Univ Cruces, Serv Neurol, Bilbao, Spain - Author
Hosp Univ Donostia, Serv Neurol, San Sebastian, Spain - Author
Hosp Univ Huelva, Serv Neurol, Huelva, Spain - Author
Hosp Univ Infanta Sofia, Secc Neurol, Madrid, Spain - Author
Hosp Univ Infanta Sofia, Serv Neurol, Madrid, Spain - Author
Hosp Univ Josep Trueta, Serv Neurol, Girona, Spain - Author
Hosp Univ La Fe, Serv Neurol, Valencia, Spain - Author
Hosp Univ La Paz Carlos III Cantoblanco, Serv Neurol, Madrid, Spain - Author
Hosp Univ Marques de Valdecilla, Serv Neurol, Cantabria, Spain - Author
Hosp Univ Miguel Servet, Serv Neurol, Zaragoza, Spain - Author
Hosp Univ Sonsoles, Serv Neurol, Avila, Spain - Author
Hosp Univ Valme, Serv Neurol, Seville, Spain - Author
Hosp Univ Virgen Nieves, Serv Neurol, Granada, Spain - Author
Hosp Univ Virgen Rocio, Serv Neurol, Seville, Spain - Author
Hosp Villarrobledo, Serv Neurol, Albacete, Spain - Author
Univ Autonoma Madrid, Hosp Clin San Carlos, Fac Med, Dept Anat Hist & Neurociencia, Madrid, Spain - Author
See more

Abstract

Introduction: Ataxia and hereditary spastic paraplegia are rare neurodegenerative syndromes. We aimed to determine the prevalence of these disorders in Spain in 2019. Patients and methods: We conducted a cross-sectional, multicentre, retrospective, descriptive study of patients with ataxia and hereditary spastic paraplegia in Spain between March 2018 and December 2019. Results: We gathered data from a total of 1933 patients from 11 autonomous communities, provided by 47 neurologists or geneticists. Mean (SD) age in our sample was 53.64 (20.51) years; 938 patients were men (48.5%) and 995 were women (51.5%). The genetic defect was unidentified in 920 patients (47.6%). A total of 1371 patients (70.9%) had ataxia and 562 (29.1%) had hereditary spastic paraplegia. Prevalence rates for ataxia and hereditary spastic paraplegia were estimated at 5.48 and 2.24 cases per 100 000 population, respectively. The most frequent type of dominant ataxia in our sample was SCA3, and the most frequent recessive ataxia was Friedreich ataxia. The most frequent type of dominant hereditary spastic paraplegia in our sample was SPG4, and the most frequent recessive type was SPG7. Conclusions: In our sample, the estimated prevalence of ataxia and hereditary spastic paraplegia was 7.73 cases per 100 000 population. This rate is similar to those reported for other countries. Genetic diagnosis was not available in 47.6% of cases. Despite these limitations, our study provides useful data for estimating the necessary healthcare resources for these patients, raising awareness of these diseases, determining the most frequent causal mutations for local screening programmes, and promoting the development of clinical trials. (c) 2021 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).

Keywords

AdultArticleAtaxiaAtaxiasCross-sectional studyDominant cerebellar-ataxiaEpidemiologiaEpidemiologyFamiliesFemaleFrequencyFriedreich ataxiaGene frequencyGene mappingGeneticGenetic disorderGenetic mapGenetic susceptibilityGenéticaGeneticistGeneticsHereditary motor sensory neuropathyHereditary spastic paraplegiaHumanMachado joseph diseaseMajor clinical studyMaleMapa genéticoMiddle agedNeurologistParaparesias espásticas hereditariasPrevalenceRecessive geneRetrospective studyScaSpain

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Neurologia due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 102/280, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Clinical Neurology. Notably, the journal is positioned en el Cuartil Q3 para la agencia Scopus (SJR) en la categoría .

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 1.51. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 1.96 (source consulted: FECYT Feb 2024)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-11-05, the following number of citations:

  • WoS: 6
  • Scopus: 10
  • Europe PMC: 1

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-11-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 40.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 48 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 8.
  • The number of mentions in news outlets: 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: France; Granada.